ESC Cardio Talk cover art

All Episodes

ESC Cardio Talk — 222 episodes

#
Title
1

Journal editorial: Standard-dose direct oral anticoagulants for Asian patients with atrial fibrillation: the definitive case from COMBINE AF

2

Journal editorial: Sex-neutral efficacy in a sex-biased care continuum: insights from finerenone in cardiovascular–kidney–metabolic syndrome

3

Journal editorial: Cancer and cardiovascular disease: converging burdens, shared challenges

4

Journal editorial: Preparing for the cardiovascular risks of tropical storms amplified by climate change

5

Journal editorial: From prescription to persistence: guideline-recommended medical therapy in heart failure with reduced ejection fraction

6

Journal editorial: Computed tomography-guided ablation of ventricular tachycardia: how predictable are VT circuits?

7

Journal editorial: Beyond ischemia and anatomy: functional capacity as a stage-specific prognostic driver in advanced coronary atherosclerosis

8

Journal editiorial: Subvalvular aortic stenosis in adulthood: stable, manageable, but never simple

9

Journal editorial: Optimizing anticoagulation quality to improve outcomes in LVAD recipients

10

Journal editorial: Walking the tightrope: balancing safety and risk in gender-affirming hormone therapy

11

Journal editorial - Cardiovascular child health in a changing climate

12

Journal editorial - Fractional flow reserve-guided percutaneous coronary intervention for transcatheter aortic valve implantation: a FAITAVI accompli for better outcomes?

13

Journal editorial - More than a sidekick: GIP signalling and cardiovascular outcomes

14

Journal Editorial - Another piece of the puzzle: long term follow-up of conduction system pacing

15

Journal editorial - Pressure-volume loops and cardiac energetics: finally, is it time to translate historical knowledge to clinical routine?

16

Journal editorial - Advanced cardiac imaging in primary prevention: the great challenge we have to achieve

17

Journal editorial - Macrophage leukotriene B4 production sustains inflammation after myocardial infarction

18

Journal editorial - The emerging story of Myval transcatheter heart valve: lessons from the LANDMARK trial

19

Journal editorial: The dilemma of a correct patient selection for implantable cardioverter defibrillator in non-ischaemic cardiomyopathy

20

Journal editorial: Is routine imaging follow-up after LAA closure necessary?

21

Journal Editorial: Perioperative discontinuation of renin–angiotensin system inhibitors in non-cardiac surgery: is it time to change what we tell our patients?

22

Journal editorial: Arrhythmic risk and advanced heart failure in dilated cardiomyopathy: a deadly tango

23

Journal editorial: ApoB and Lp(a): core measures to assess cardiovascular risk

24

Journal editorial: With a little HELP from heparin at first medical contact before primary percutaneous coronary intervention

25

Journal editorial - Residual cardiovascular risk beyond low-density lipoprotein cholesterol: inflammation, remnant cholesterol, and lipoprotein(a)

26

Journal editorial - Has artificial intelligence proven stress perfusion cardiac computed tomography obsolete or more relevant than ever?

27

Journal editorial - When coronary plaque is found in everyone: is anyone really at risk?

28

Journal editorial - Predicting the diastolic left ventricular pressure curve non-invasively: how far can echo go?

29

Journal editorial - Artificial intelligence–derived stress ejection fraction in stress cardiac magnetic resonance with dipyridamole: bridging past insights with future innovations

30

Journal editorial - T1 mapping is not ready to replace the use of contrast agents in stress CMR

31

Journal editorial - The emerging role of left atrioventricular coupling index (LACI) in heart failure: a new frontier for CMR

32

Journal editorial - Accelerated pacing as a treatment for heart failure with preserved ejection fraction and atrial fibrillation?

33

Journal editorial - Multivalvular diseases: look beyond the valves - no way home

34

Journal editorial - Another piece in the puzzle of atrial fibrillation risk: clinical, genetic, and electrocardiogram-based artificial intelligence

35

Journal editorial - The challenge of interpreting cardiac adaptation to exercise: the importance of picking up the training history

36

Journal Editorial - Familial hypercholesterolaemia: need for equitable treatment in women and men

37

Journal Editorial - Valvular heart disease: the oncoming tsunami

38

Journal Editorial - Challenge–skill balance in cardiac surgery: an attempt to explain sex-related differences in coronary surgery

39

Journal Editorial - Looking beyond the right ventricular strain: right atrial strain in arrhythmogenic right ventricular cardiomyopathy

40

Journal Editorial - Quantitative myocardial perfusion and the power of numbers

41

Journal Editorial - Artificial intelligence-enhanced exposomics: novel insights into cardiovascular health

42

Journal Editorial - Breathing danger: linking air pollution to cardiovascular disease and increased risk of abdominal aortic aneurysm

43

Journal Editorial - Transatlantic differences in the use of implantable cardioverter defibrillators in arrhythmogenic right ventricular cardiomyopathy

44

Journal Editorial - Post-ablation cardiac magnetic resonance in ventricular tachycardia ablation: shining light on dark cores and corridors

45

Journal Editorial - Tracking changes in 'healthy sleep' for cardiovascular risk assessment

46

Journal Editorial - Prime time for CMR imaging of arrhythmogenic substrate in hypertrophic cardiomyopathy

47

Journal Editorial - Long-term risk for atrial and ventricular arrhythmias: a cardinal manifestation of 'the epileptic heart

48

Journal Editorial - Modelling relations between blood pressure, cardiovascular phenotype, and clinical factors using large scale imaging data

49

Journal Editorial - Sodium–glucose co-transporter 2 inhibitors and mineralocorticoid receptor antagonists synergism in heart failure: it takes two to tango

50

Journal Editorial - Aortic stenosis: new insights into predicting disease progression

51

Journal Editorial - Primary mitral regurgitation and risk models for predicting outcome: time to move to artificial intelligence?

52

Journal Editorial - Translating HARMS2-AF into benefits for our atrial fibrillation patients and the general public: challenges and opportunities

53

Journal Editorial - Trouble with estimating filling pressure in acute heart failure: lessons from Takotsubo syndrome

54

Journal Editorial - How to treat left main coronary artery disease: the complementary lessons from trials and registries

55

Journal Editorial - Tilt testing evolves: faster and still accurate

56

Journal Editorial - The never-ending hunt for risk predictors in hypertrophic cardiomyopathy: the role of cardiac magnetic resonance tissue characterization

57

Journal Editorial - Best timing for exercise in breast cancer patients initiating chemotherapy: what is the answer?

58

Journal Editorial - Hypertension, brain imaging phenotypes, and cognitive impairment: lessons from Mendelian randomization

59

Journal Editorial - Why Y? The Y chromosome may serve a cardiovascular purpose after all

60

Journal Editorial - C-reactive protein in people with high lipoprotein a: a partner in crime or an innocent bystander?

61

Journal Editorial - Reassurance for parents with children born via assisted reproductive technology or too soon to tell?

62

Journal Editorial - Pregnancy outcomes in women with heart disease: how to improve?

63

Journal Editorial - Are we getting closer to treating heart and mind together and bridging the gap for individual patients attending cardiac rehabilitation?

64

Journal Editorial - Histiocytes set on the heart: cardiac complications of Erdheim–Chester disease

65

Journal Editorial - Cancer is a comorbidity of heart failure

66

Journal Editorial - Moving beyond lifestyle: the case for childhood adversity, social determinants of health, and psychosocial factors in cardiovascular risk prediction

67

Journal Editorial - Wideband cardiac magnetic resonance for myocardial tissue characterization in patients with implantable cardioverter defibrillators

68

Journal Editorial - Assessing and treating congestion in acute decompensated heart failure: are we seeing the light at the end of the tunnel?

69

Journal Editorial - SGLT2 inhibitors in heart failure: insights from plasma proteomics

70

Journal Editorial - Current role of coronary calcium in younger population and future prospects with photon counting technology

71

Journal Editorial - Subcutaneous implantable cardioverter defibrillator for the prevention of sudden cardiac death: ready for prime-time?

72

Journal Editorial - Arrhythmogenic cardiomyopathies in children: seek and you shall find

73

Journal Editorial - Sinus rhythm: The sine qua non for rhythm control?

74

Journal Editorial - Potassium binders for patients with heart failure? The real enlightenment of the DIAMOND trial

75

Journal Editorial - Management of patients with ischaemic cardiomyopathy: is there still a role for ischaemia-guided revascularization?

76

Journal Editorial - Targeting pulmonary hypertension in patients with heart failure and preserved ejection fraction: rather static than DYNAMIC development?

77

Journal Editorial - Post-operative AF and heart failure hospitalizations: what remains hidden in patients undergoing surgery

78

Journal Editorial - Characteristics and natural history of early-stage cardiac transthyretin amyloidosis

79

Journal Editorial - Shedding light on the pathophysiology of non-valvular atrial fibrillation as a primary cause of the regurgitation of atrio-ventricular valves

80

Journal Editorial - Orchestration of vascular smooth muscle cell plasticity using epigenetic therapy

81

Journal Editorial - Left atrial strain imaging: ready for clinical implementation in heart failure with preserved ejection fraction

82

Journal Editorial - Converging on the distribution profile of coronary artery disease

83

Journal Editorial - Long-term results of first-generation S-ICD systems: strong from the start and through the threats of time

84

Journal Editorial - Statin intolerance: how common is it and how do we work with patients to overcome it?

85

Journal Editorial - Advancing population-scale access to high-value cardiovascular care: a roadmap for CMR and beyond

86

Journal Editorial - Time for a paradigm shift? Making the case for tailored selection of antiplatelet therapy

87

Journal Editorial - Proteomics for the prediction and prevention of atherosclerotic disease

88

Journal Editorial - Cardiac computed tomography as a complete functional tool

89

Journal Editorial - Triggers of stroke: anger, emotional upset, and heavy physical exertion. New insights from the INTERSTROKE study

90

Journal Editorial - Coronary flow reserve: a versatile tool for interrogating pathophysiology, and a reliable marker of cardiovascular outcomes and mortality

91

Journal Editorial - Haemodynamic response to COVID-19 and its outcome implications

92

Journal Editorial - 'State of the Art' PCI: bridging the implementation gap

93

Journal Editorial - Cardioprotection in breast cancer patients: one size fits all?

94

Journal Editorial - The untapped potential of reproductive history in cardiovascular disease

95

Journal Editorial - Atrial fibrillation and breast cancer: casual or causal relationship?

96

Journal Editorial - Women and cardiac rehabilitation: Moving beyond barriers to solutions?

97

Journal Editorial - Left ventricular performance by work and wasted energy: is strain not sufficient?

98

Journal Editorial - Aortic valve calcification score utility extended to moderate aortic stenosis

99

Journal Editorial - PCSK9 inhibition for acute arterial events: more than LDL lowering

100

Journal Editorial - When tissue and outcomes are the issue. Cardiac magnetic resonance for patients with suspected cardiac tumours

101

Journal Editorial - Immune checkpoint inhibitors and cardiovascular events among patients with cancer: a window into the critical role of the immune system in cardiovascular biology

102

Journal Editorial - Investigating contrasting results in REDUCE-IT and STRENGTH: partial answers but questions remain

103

Journal Editorial - Impact of hypertensive disorders of pregnancy: lessons from CONCEPTION

104

Journal Editorial - Sudden cardiac death in hypertrophic cardiomyopathy: time to change the narrative

105

Journal Editorial - Does early angiography pave the way for improved outcomes in patients with acute heart failure?

106

Journal Editorial - Pace and ablate better than drugs in patients with heart failure and atrial fibrillation: lessons from the APAF-CRT mortality trial

107

Journal Editorial - Novel actors on the stage of cardiac dysfunction induced by anti-PD1 oncological treatments

108

Journal Editorial - Key roles of five lifestyle risk factors in the harmful transition from a healthy condition to multimorbidity in the Chinese population

109

ESC Guidelines 2021 on valvular heart disease

110

Journal Editorial - First, do no harm

111

ESC Guidelines 2021 on cardiac pacing and cardiac resynchronization therapy

112

Journal Editorial - Decoding the link between heart failure and incident cancer

113

Journal Editorial - The endothelial niche in heart failure: from development to regeneration

114

Journal Editorial - Initiation and management of polymorphic ventricular tachycardia: history gone full circle

115

Journal Editorial - Genome-wide association analysis in dilated cardiomyopathy reveals two new players in systolic heart failure on chromosomes 3p25.1 and 22q11.23

116

Journal Editorial - Beat-to-beat variability occurs not only in atrial fibrillation: clinical value of dynamic assessment of the mitral and tricuspid annulus

117

Journal Editorial - Optical coherence tomography and vulnerable plaque detection: how far are we willing to stray from true histology?

118

Journal Editorial - Redefining cardiovascular risk prediction: is the crystal ball clearer now?

119

Journal Editorial - Physical exercise is cardioprotective, but detrimental for the heart in high air pollution areas

120

Journal Editorial - Can we turn heart failure into heart success by studying myocardial remission?

121

Journal Editorial - Decoding stroke risk scores in atrial fibrillation and CKD: still more work to do

122

Journal Editorial - Childhood-onset hypertrophic cardiomyopathy research coming of age

123

Journal Editorial - Low sudden cardiac death risk in hypertrophic cardiomyopathy: 'A wolf in a lamb's skin'?

124

Journal Editorial - Silent brain infarcts and early cognitive outcomes after transcatheter aortic valve implantation: a systematic review and meta-analysis

125

Journal Editorial - Left atrial strain: evaluating left ventricular filling pressure from an upstream vantage point

126

Journal Editorial - Alcohol consumption, cardiac biomarkers, and risk of atrial fibrillation and adverse outcomes

127

Journal Editorial - C-reactive protein predicts outcome in COVID-19: is it also a therapeutic target?

128

Journal Editorial - Heart failure, cognition, and brain damage

129

Journal Editorial - A broken heart after child loss

130

Journal Editorial - Predicted benefit of an implantable cardioverter-defibrillator: the MADIT-ICD benefit score

131

Journal Editorial - Multisystem positron emission tomography: interrogating vascular inflammation, emotional stress, and bone marrow activity in a single scan

132

Journal Editorial - Lifelong low Lp(a) levels: genetics give a green light?

133

Journal Editorial - What we (don't) know about myocardial injury after COVID-19

134

ESC Cardio Talk - Perspective - Long term effects of COVID-19

135

Journal Editorial - Heart failure and systolic function: time to leave diagnostics based on ejection fraction?

136

Journal Editorial - Heart failure drug treatment: the fantastic four

137

Journal Editorial - Illuminating the path from genetics to clinical outcome in Brugada syndrome

138

Journal Editorial - Long, longer, long QT syndrome: what makes the difference?

139

Journal Editorial - Changing the paradigm for post-MI cholesterol lowering from intensive statin monotherapy towards intensive lipid-lowering regimens and individualized care

140

Journal Editorial - Noise and cardiovascular risk: nighttime aircraft noise acutely triggers cardiovascular death

141

Journal Editorial - COVID-19 pandemic: complex interactions with the arrhythmic profile and the clinical course of patients with cardiovascular disease

142

Journal Editorial - A fundamental principle of coronary pathophysiology for risk stratifying coronary artery disease

143

Journal Editorial - Secondary tricuspid regurgitation: neglected no more!

144

Journal Editorial - Are we underestimating the potential for cardiotoxicity related to immune checkpoint inhibitors?

145

Journal Editorial - Aspirin or P2Y12 inhibition: establishing the cornerstone of antiplatelet therapy after stenting

146

Journal Editorial - Less dementia after catheter ablation for atrial fibrillation: a nationwide cohort study

147

Journal Editorial - Measure or predict prosthesis–patient mismatch?

148

Journal Editorial - The sooner, the better: anti-inflammation in acute myocardial infarction

149

Journal Editorial - CD8 lymphocytes and plaque erosion: a new piece in the jigsaw

150

Journal Editorial - Non-vitamin K oral anticoagulants in adults with congenital heart disease: quod non?

151

Journal Editorial - Personalised medicine for dilated cardiomyopathy

152

Journal Editorial - Sex differences among young individuals with myocardial infarction

153

Journal Editorial - Evaluating risk of dementia in older people: a pathway to personalized prevention?

154

Journal Editorial - Global longitudinal strain in severe aortic stenosis

155

Journal Editorial - Transcatheter valve-in-valve implantation in failed aortic bioprosthetic valves: a word of caution in times of euphoria

156

Journal Editorial - Defining circulating mononuclear cells in heart failure through single-cell RNA sequencing: new insights for an old disease

157

Journal Editorial - Sex differences and the left ventricle: morphology matters

158

Journal Editorial - Electro-mechanics or mechano-electrics, an intricate interplay - STANISLAS cohort insights

159

Journal Editorial - A highly specific biomarker for Brugada syndrome. Too good to be true?

160

Journal Editorial - Insights from physiology applied to interpretation of supranormal ejection fraction in women

161

Journal Editorial - Does atrial fibrillation affect the tricuspid annulus 3D geometry in patients without severe valve regurgitation?

162

Journal Editorial - Air pollution health impacts: the knowns and unknowns

163

The effect of intracoronary infusion of bone marrow-derived mononuclear cells on all-cause mortality in acute myocardial infarction: The BAMI Trial

164

Edoxaban in atrial fibrillation patients with percutaneous coronary intervention by acute or chronic coronary syndrome presentation: a pre-specified analysis of the ENTRUST-AF PCI trial

165

Catheter ablation versus thoracoscopic surgical ablation in long standing persistent atrial fibrillation (CASA-AF) - A randomised control trial

166

Journal Editorial - Regression of left ventricular hypertrophy with SGLT2 inhibitors

167

Journal Editorial - It's time to personalise and optimise lipid-lowering therapy

168

Journal Editorial - Sex differences in aortic dissection

169

Journal Editorial - How COVID-19 lockdown impacts outcomes of patients with new onset AFib

170

Journal Editorial - Comparing the 2019 and 2016 ESC/EAS dyslipidaemia guidelines

171

Journal Editorial - Revascularization of ischaemic myocardium: still valuable in patients with stable CAD?

172

Journal Editorial - The Metabolic Signature: An Emerging Paradigm in Cardiovascular Nutritional Research?

173

Journal Editorial - Simple electrocardiographic measures improve sudden arrhythmic death prediction in coronary disease

174

Journal Editorial - Right Ventricular Dysfunction and Outcome: Aetiology Matters

175

Journal Editorial - Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts

176

Journal Editorial - SARS-CoV2: Use of inhibitors of the renin-angiotensin system in patients with COVID-19

177

Journal Editorial - Non-obstructive coronary artery disease can no longer be ignored

178

Journal Editorial - Sex differences and higher upper normal limits for left atrial end-systolic volume in individuals in their mid-60s

179

Journal Editorial - Vitamin K antagonists and osteoporotic fractures: insights from comparisons with the NOACs

180

Journal Editorial - Secondary prevention medications after coronary artery bypass grafting and long-term survival: A population-based longitudinal study from the SWEDEHEART registry

181

Journal Editorial - Does type 2 diabetes confer higher relative rates of cardiovascular events in women compared with men?

182

Journal Editorial - Implantable cardioverter-defibrillators in previously undiagnosed patients with catecholaminergic polymorphic ventricular tachycardia resuscitated from sudden cardiac arrest

183

Journal Editorial - A population-based study of cardiovascular disease mortality risk in US cancer patients

184

Journal Editorial - Short-term e-cigarette vapour exposure causes vascular oxidative stress and dysfunction

185

Journal Editorial - Cardiovascular effect of discontinuing statins for primary prevention at the age of 75 years

186

Journal Editorial - The association between the public reporting of individual operator outcomes with patient profiles, procedural management, and mortality after percutaneous coronary intervention

187

Journal Editorial - Sudden death in cardiac sarcoidosis: an analysis of nationwide clinical and cause-of-death registries

188

Journal Editorial - A new opening on aortic stenosis: predicting prognosis with clonal haematopoiesis

189

Journal Editorial - Periodontitis and hypertension: causally linked by immune mechanisms

190

ESC Digital Summit 2019 - Risk prediction & communication.

191

Journal Editorial - Promoting physical activity in primary and secondary prevention

192

Journal Editorial - Development and validation of a multivariable prediction model for major adverse cardiovascular events after early stage breast cancer

193

Journal Editorial - Thromboembolic events around the time of cardioversion for atrial fibrillation.

194

ESC Congress - Results of the European Infective Endocarditis registry (ESC-EORP EURO-ENDO)

195

ESC Congress 2019 - Is perivascular fat a new cardiovascular risk factor? Results of SCOT-HEART

196

ESC Congress 2019 - DANAMI-2 - 16-year follow-up of the Danish Acute Myocardial Infarction 2 trial - Primary percutaneous coronary intervention versus fibrinolysis in ST-elevation myocardial infarction

197

ESC Congress 2019 - Residual Inflammatory Risk Associated with Interleukin-18 and Interleukin-6

198

ESC Congress 2019 - The relation between systemic inflammation and incident cancer in patients with stable cardiovascular disease, a cohort study

199

ESC Congress 2019 - Estimating individual lifetime benefit and bleeding risk of adding rivaroxaban to aspirin for patients with stable cardiovascular disease: results from the COMPASS trial

200

ESC Congress 2019 - High penetrance and similar disease progression in probands and in family members with arrhythmogenic cardiomyopathy

201

ESC Congress 2019 - Relationship between hypoglycaemia, outcomes and empagliflozin treatment effect in EMPA-REG OUTCOME

202

Journal Editorial - Defining high bleeding risk in patients undergoing percutaneous coronary intervention

203

Journal Editorial - Transcatheter heart valve migration and embolization: rare and preventable?

204

Journal Editorial - Measuring coronary microvascular function: is it finally ready for prime time?

205

Journal Editorial - Longevity-associated variant BPIFB4 gene transfer to recapitulate healthy ageing in patients at risk: is the future around the corner?

206

Journal Editorial - PCSK9 inhibitors: what we know, what we should have understood, and what is to come

207

Journal Editorial - Continuous anticoagulation with catheter ablation: answers and questions

208

Journal Perspective - Cardiac arrest in takotsubo syndrome: results from the InterTAK Registry

209

Journal Editorial - Transcatheter pulmonary valve implantation: a melody to follow

210

Journal Editorial - Frequency, predictors, and prognosis of ejection fraction improvement in heart failure: an echocardiogram-based registry study

211

Journal Editorial - The future of functional mitral regurgitation treatment

212

Journal Editorial - Left ventricular non-compaction: have we reached the limits of conventional imaging?

213

Journal Editorial - Impact of Preoperative FFR on Arterial Bypass Graft Anastomotic Function: the IMPAG trial

214

Journal Editorial - Targeting RNA to lower triglycerides: long strides from short molecules 🎙️

215

Heart Failure 2019 - My Take Home Messages on novel treatments in heart failure on ESC-HF

216

EuroPrevent 2019 - Exercise and atrial fibrillation what to consider?

217

EuroPrevent 2019 - Sugar tax – The right answer on a complex metabolism

218

Journal Editorial - Blood pressure target in diabetics: how low is too low?

219

Journal Editorial - Cardiovascular Disease and Uric Acid

220

Journal Editorial - How to target vascular inflammation in the post-CANTOS era?

221

Journal Editorial - Atrial Fibrillation, with ACS and PCI: walking a tightrope

222

Lecture Series - Digital Health Revolution: The Rewards